113 related articles for article (PubMed ID: 17408384)
1. 4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor.
Tveten K; Holla ØL; Ranheim T; Berge KE; Leren TP; Kulseth MA
FEBS J; 2007 Apr; 274(8):1881-93. PubMed ID: 17408384
[TBL] [Abstract][Full Text] [Related]
2. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis.
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1683-90. PubMed ID: 17389500
[TBL] [Abstract][Full Text] [Related]
3. The di-leucine motif contributes to class a scavenger receptor-mediated internalization of acetylated lipoproteins.
Chen Y; Wang X; Ben J; Yue S; Bai H; Guan X; Bai X; Jiang L; Ji Y; Fan L; Chen Q
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1317-22. PubMed ID: 16574888
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological rescue of carnitine transport in primary carnitine deficiency.
Amat di San Filippo C; Pasquali M; Longo N
Hum Mutat; 2006 Jun; 27(6):513-23. PubMed ID: 16652335
[TBL] [Abstract][Full Text] [Related]
5. Functional rescue of a defective angiotensin II AT1 receptor mutant by the Mas protooncogene.
Santos EL; Reis RI; Silva RG; Shimuta SI; Pecher C; Bascands JL; Schanstra JP; Oliveira L; Bader M; Paiva AC; Costa-Neto CM; Pesquero JB
Regul Pept; 2007 Jun; 141(1-3):159-67. PubMed ID: 17320985
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of low-density lipoprotein receptor in homozygous familial hypercholesterolemia patients with novel 1439 C-->T mutation of low-density lipoprotein receptor gene.
Lin J; Wang LY; Liu S; Xia JH; Yong Q; Du LP; Pan XD; Xue H; Chen BS; Jiang ZS
Chin Med J (Engl); 2008 May; 121(9):776-81. PubMed ID: 18701038
[TBL] [Abstract][Full Text] [Related]
7. Low-density lipoprotein receptor structure and folding.
Gent J; Braakman I
Cell Mol Life Sci; 2004 Oct; 61(19-20):2461-70. PubMed ID: 15526154
[TBL] [Abstract][Full Text] [Related]
8. Retention of mutant low density lipoprotein receptor in endoplasmic reticulum (ER) leads to ER stress.
Sørensen S; Ranheim T; Bakken KS; Leren TP; Kulseth MA
J Biol Chem; 2006 Jan; 281(1):468-76. PubMed ID: 16257961
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein receptor--its structure, function, and mutations.
Defesche JC
Semin Vasc Med; 2004 Feb; 4(1):5-11. PubMed ID: 15199428
[TBL] [Abstract][Full Text] [Related]
11. Computational diagnosis of protein conformational diseases: short molecular dynamics simulations reveal a fast unfolding of r-LDL mutants that cause familial hypercholesterolemia.
Cuesta-López S; Falo F; Sancho J
Proteins; 2007 Jan; 66(1):87-95. PubMed ID: 17044057
[TBL] [Abstract][Full Text] [Related]
12. Mammalian cell expression of an active site mutant of Pseudomonas exotoxin disrupts LRP1 maturation.
Pastrana DV; Yun CH; McKee ML; Fitzgerald DJ
J Biomed Sci; 2008 Jul; 15(4):427-39. PubMed ID: 18351442
[TBL] [Abstract][Full Text] [Related]
13. The cytoplasmic domain is not involved in directing Class 5 mutant LDL receptors to lysosomal degradation.
Strøm TB; Tveten K; Holla ØL; Cameron J; Berge KE; Leren TP
Biochem Biophys Res Commun; 2011 May; 408(4):642-6. PubMed ID: 21531209
[TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
17. The binding sites for the very low density lipoprotein receptor and low-density lipoprotein receptor-related protein are shared within coagulation factor VIII.
Ananyeva NM; Makogonenko YM; Kouiavskaia DV; Ruiz J; Limburg V; Meijer AB; Khrenov AV; Shima M; Strickland DK; Saenko EL
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):166-77. PubMed ID: 18277139
[TBL] [Abstract][Full Text] [Related]
18. 4-Phenylbutyrate rescues trafficking incompetent mutant alpha-galactosidase A without restoring its functionality.
Yam GH; Roth J; Zuber C
Biochem Biophys Res Commun; 2007 Aug; 360(2):375-80. PubMed ID: 17592721
[TBL] [Abstract][Full Text] [Related]
19. Two novel mutations of the LDL receptor gene associated with familial hypercholesterolemia in a Chinese family.
Xie L; Gong QH; Xie ZG; Liang ZM; Hu ZM; Xia K; Xia JH; Yang YF
Chin Med J (Engl); 2007 Oct; 120(19):1694-9. PubMed ID: 17935672
[TBL] [Abstract][Full Text] [Related]
20. Lectin-like oxidized low-density lipoprotein receptor (LOX-1) functions as an oligomer and oligomerization is dependent on receptor density.
Matsunaga S; Xie Q; Kumano M; Niimi S; Sekizawa K; Sakakibara Y; Komba S; Machida S
Exp Cell Res; 2007 Apr; 313(6):1203-14. PubMed ID: 17306253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
